Drug Research

Adoptive cell therapy has gone on to become a promising immunotherapy tool that can be used to help in the treatment of advanced melanoma. The therapy, which makes use of the immune cells that are collected from the individual's...

Each cell in the body puts in considerable energy to maintain the proper balance of water and critical electrolytes in order to survive. Researchers at Oregon Health & Science University (OHSU) have gone on to develop a way for...

A study has gone on to find that monoclonal antibodies (mAbs) decreased the risk of hospitalisation or even death by 39% if given within two days to people who are tested positive for COVID-19. The research compared the patients who...

Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new targets when it comes to developing antibiotics. Professor Mark Schembri and Professor Mark Walker from the...

Scynexis entered into an exclusive agreement with GSK for Brexafemme (ibrexafungerp), a U.S. FDA approved antifungal for the treatment of vaginal yeast infections and vulvovaginal candidiasis (VVC). Under the terms of the global license agreement, GSK will pay Scynexis $90 million upfront, plus...

Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), Wacker Chemie AG and CordenPharma International GmbH have launched a project to accelerate the development of RNA-based drugs. The aim is to develop a...

Drug manufacturers are not able to provide Europeans with the required information to gauge the benefits and defects of oncology medicines. This is as per the findings published in The BMJ, which demonstrate that the patient information leaflets consistently...